Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Hepion Pharmaceuticals Inc. (HEPA)

  • Technical Exchange News
  • May 12, 2025, 19:17 UTC
  • 7

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

CASI Pharmaceuticals Inc. (CASI)

  • Technical Exchange News
  • May 12, 2025, 19:17 UTC
  • 9

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Jin Medical International Ltd (ZJYL)

  • Technical Exchange News
  • May 10, 2025, 01:57 UTC
  • 9

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Jin Medical International Ltd (ZJYL)

  • Technical Exchange News
  • May 09, 2025, 19:34 UTC
  • 9

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

LIVEPERSON (LPSN)

  • Technical Exchange News
  • May 09, 2025, 03:53 UTC
  • 12

LIVEPERSON (LPSN) was added to the list of traded instruments on TASE exchange

Comment Full text

Rani Therapeutics LLC (RANI)

  • Technical Exchange News
  • May 09, 2025, 01:44 UTC
  • 11

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Nautilus Biotechnology Inc (NAUT)

  • Technical Exchange News
  • May 09, 2025, 01:44 UTC
  • 12

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Biomerica Inc. (BMRA)

  • Technical Exchange News
  • May 09, 2025, 01:44 UTC
  • 11

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Rani Therapeutics LLC (RANI)

  • Technical Exchange News
  • May 08, 2025, 19:19 UTC
  • 11

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Nautilus Biotechnology Inc (NAUT)

  • Technical Exchange News
  • May 08, 2025, 19:19 UTC
  • 11

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 44
  • 45
  • 46
  • 47
  • 48
  • Next

Search

News categories

  • Technical Exchange News(9492)
  • Event(407)
  • SEC News(155849)
  • FDA Approval(8880)
  • Company Report(721)
  • Business News(105720)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin